Request for Covid-19 Impact Assessment of this Report
Scope of the Report:
This report focuses on the Anti-inflammatory Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The global anti-inflammatory therapeutics market will grow steadily at a CAGR of over 6% by 2021. This market research analysis identifies the increase in the prevalence of immune-mediated inflammatory disease (IMID) as one of the primary growth factors for this market. IMID includes a group of disabling conditions that share a common inflammatory pathway including conditions like ankylosing spondylitis (AS), ulcerative colitis, multiple sclerosis (MS), rheumatoid arthritis (RA), and inflammatory bowel disease (IBD) and these conditions can affect an organ, resulting in significant morbidity and reduced quality of life.
The worldwide market for Anti-inflammatory Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
AbbVie
Amgen
Johnson & Johnson
Pfizer
Boehringer Ingelheim
Eli Lilly
Novartis
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Anti-Inflammatory Biologicals
NSAIDs
Corticosteroids
Market Segment by Applications, can be divided into
Hospitals
Clinics
There are 15 Chapters to deeply display the global Anti-inflammatory Therapeutics market.
Chapter 1, to describe Anti-inflammatory Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Anti-inflammatory Therapeutics, with sales, revenue, and price of Anti-inflammatory Therapeutics, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Anti-inflammatory Therapeutics, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Anti-inflammatory Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Anti-inflammatory Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
1 Market Overview
1.1 Anti-inflammatory Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Anti-Inflammatory Biologicals
1.2.2 NSAIDs
1.2.3 Corticosteroids
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Clinics
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 Business Overview
2.1.2 Anti-inflammatory Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AbbVie Anti-inflammatory Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Amgen
2.2.1 Business Overview
2.2.2 Anti-inflammatory Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Amgen Anti-inflammatory Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Johnson & Johnson
2.3.1 Business Overview
2.3.2 Anti-inflammatory Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Johnson & Johnson Anti-inflammatory Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Anti-inflammatory Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Anti-inflammatory Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Boehringer Ingelheim
2.5.1 Business Overview
2.5.2 Anti-inflammatory Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Boehringer Ingelheim Anti-inflammatory Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Eli Lilly
2.6.1 Business Overview
2.6.2 Anti-inflammatory Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Eli Lilly Anti-inflammatory Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Novartis
2.7.1 Business Overview
2.7.2 Anti-inflammatory Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Novartis Anti-inflammatory Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Anti-inflammatory Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Anti-inflammatory Therapeutics Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Anti-inflammatory Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Anti-inflammatory Therapeutics Manufacturer Market Share in 2017
3.3.2 Top 6 Anti-inflammatory Therapeutics Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Anti-inflammatory Therapeutics Market Analysis by Regions
4.1 Global Anti-inflammatory Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global Anti-inflammatory Therapeutics Sales and Market Share by Regions (2013-2018)
4.1.2 Global Anti-inflammatory Therapeutics Revenue and Market Share by Regions (2013-2018)
4.2 North America Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
4.3 Europe Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
4.5 South America Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
5 North America Anti-inflammatory Therapeutics by Countries
5.1 North America Anti-inflammatory Therapeutics Sales, Revenue and Market Share by Countries
5.1.1 North America Anti-inflammatory Therapeutics Sales and Market Share by Countries (2013-2018)
5.1.2 North America Anti-inflammatory Therapeutics Revenue and Market Share by Countries (2013-2018)
5.2 United States Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
5.3 Canada Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
5.4 Mexico Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
6 Europe Anti-inflammatory Therapeutics by Countries
6.1 Europe Anti-inflammatory Therapeutics Sales, Revenue and Market Share by Countries
6.1.1 Europe Anti-inflammatory Therapeutics Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Anti-inflammatory Therapeutics Revenue and Market Share by Countries (2013-2018)
6.2 Germany Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
6.3 UK Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
6.4 France Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
6.5 Russia Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
6.6 Italy Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
7 Asia-Pacific Anti-inflammatory Therapeutics by Countries
7.1 Asia-Pacific Anti-inflammatory Therapeutics Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Anti-inflammatory Therapeutics Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Anti-inflammatory Therapeutics Revenue and Market Share by Countries (2013-2018)
7.2 China Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
7.3 Japan Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
7.4 Korea Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
7.5 India Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
8 South America Anti-inflammatory Therapeutics by Countries
8.1 South America Anti-inflammatory Therapeutics Sales, Revenue and Market Share by Countries
8.1.1 South America Anti-inflammatory Therapeutics Sales and Market Share by Countries (2013-2018)
8.1.2 South America Anti-inflammatory Therapeutics Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
8.3 Argentina Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
8.4 Colombia Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
9 Middle East and Africa Anti-inflammatory Therapeutics by Countries
9.1 Middle East and Africa Anti-inflammatory Therapeutics Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Anti-inflammatory Therapeutics Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Anti-inflammatory Therapeutics Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
9.3 UAE Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
9.4 Egypt Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
9.5 Nigeria Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
9.6 South Africa Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
10 Global Anti-inflammatory Therapeutics Market Segment by Type
10.1 Global Anti-inflammatory Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Anti-inflammatory Therapeutics Sales and Market Share by Type (2013-2018)
10.1.2 Global Anti-inflammatory Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Anti-Inflammatory Biologicals Sales Growth and Price
10.2.1 Global Anti-Inflammatory Biologicals Sales Growth (2013-2018)
10.2.2 Global Anti-Inflammatory Biologicals Price (2013-2018)
10.3 NSAIDs Sales Growth and Price
10.3.1 Global NSAIDs Sales Growth (2013-2018)
10.3.2 Global NSAIDs Price (2013-2018)
10.4 Corticosteroids Sales Growth and Price
10.4.1 Global Corticosteroids Sales Growth (2013-2018)
10.4.2 Global Corticosteroids Price (2013-2018)
11 Global Anti-inflammatory Therapeutics Market Segment by Application
11.1 Global Anti-inflammatory Therapeutics Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Clinics Sales Growth (2013-2018)
12 Anti-inflammatory Therapeutics Market Forecast (2018-2023)
12.1 Global Anti-inflammatory Therapeutics Sales, Revenue and Growth Rate (2018-2023)
12.2 Anti-inflammatory Therapeutics Market Forecast by Regions (2018-2023)
12.2.1 North America Anti-inflammatory Therapeutics Market Forecast (2018-2023)
12.2.2 Europe Anti-inflammatory Therapeutics Market Forecast (2018-2023)
12.2.3 Asia-Pacific Anti-inflammatory Therapeutics Market Forecast (2018-2023)
12.2.4 South America Anti-inflammatory Therapeutics Market Forecast (2018-2023)
12.2.5 Middle East and Africa Anti-inflammatory Therapeutics Market Forecast (2018-2023)
12.3 Anti-inflammatory Therapeutics Market Forecast by Type (2018-2023)
12.3.1 Global Anti-inflammatory Therapeutics Sales Forecast by Type (2018-2023)
12.3.2 Global Anti-inflammatory Therapeutics Market Share Forecast by Type (2018-2023)
12.4 Anti-inflammatory Therapeutics Market Forecast by Application (2018-2023)
12.4.1 Global Anti-inflammatory Therapeutics Sales Forecast by Application (2018-2023)
12.4.2 Global Anti-inflammatory Therapeutics Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Anti-inflammatory Therapeutics Picture
Table Product Specifications of Anti-inflammatory Therapeutics
Figure Global Sales Market Share of Anti-inflammatory Therapeutics by Types in 2017
Table Anti-inflammatory Therapeutics Types for Major Manufacturers
Figure Anti-Inflammatory Biologicals Picture
Figure NSAIDs Picture
Figure Corticosteroids Picture
Figure Anti-inflammatory Therapeutics Sales Market Share by Applications in 2017
Figure Hospitals Picture
Figure Clinics Picture
Figure United States Anti-inflammatory Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Anti-inflammatory Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Anti-inflammatory Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Anti-inflammatory Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure France Anti-inflammatory Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure UK Anti-inflammatory Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Anti-inflammatory Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Anti-inflammatory Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure China Anti-inflammatory Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Anti-inflammatory Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Anti-inflammatory Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure India Anti-inflammatory Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Anti-inflammatory Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Anti-inflammatory Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Anti-inflammatory Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Anti-inflammatory Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Anti-inflammatory Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Anti-inflammatory Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Anti-inflammatory Therapeutics Type and Applications
Table AbbVie Anti-inflammatory Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Anti-inflammatory Therapeutics Type and Applications
Table Amgen Anti-inflammatory Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Anti-inflammatory Therapeutics Type and Applications
Table Johnson & Johnson Anti-inflammatory Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Anti-inflammatory Therapeutics Type and Applications
Table Pfizer Anti-inflammatory Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Anti-inflammatory Therapeutics Type and Applications
Table Boehringer Ingelheim Anti-inflammatory Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Anti-inflammatory Therapeutics Type and Applications
Table Eli Lilly Anti-inflammatory Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Anti-inflammatory Therapeutics Type and Applications
Table Novartis Anti-inflammatory Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Anti-inflammatory Therapeutics Sales by Manufacturer (2016-2017)
Figure Global Anti-inflammatory Therapeutics Sales Market Share by Manufacturer in 2016
Figure Global Anti-inflammatory Therapeutics Sales Market Share by Manufacturer in 2017
Table Global Anti-inflammatory Therapeutics Revenue by Manufacturer (2016-2017)
Figure Global Anti-inflammatory Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Global Anti-inflammatory Therapeutics Revenue Market Share by Manufacturer in 2017
Figure Top 3 Anti-inflammatory Therapeutics Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Anti-inflammatory Therapeutics Manufacturer (Revenue) Market Share in 2017
Figure Global Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
Figure Global Anti-inflammatory Therapeutics Revenue and Growth Rate (2013-2018)
Table Global Anti-inflammatory Therapeutics Sales by Regions (2013-2018)
Table Global Anti-inflammatory Therapeutics Sales Market Share by Regions (2013-2018)
Table Global Anti-inflammatory Therapeutics Revenue by Regions (2013-2018)
Figure Global Anti-inflammatory Therapeutics Revenue Market Share by Regions in 2013
Figure Global Anti-inflammatory Therapeutics Revenue Market Share by Regions in 2017
Figure North America Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
Figure Europe Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
Figure South America Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
Figure North America Anti-inflammatory Therapeutics Revenue and Growth Rate (2013-2018)
Table North America Anti-inflammatory Therapeutics Sales by Countries (2013-2018)
Table North America Anti-inflammatory Therapeutics Sales Market Share by Countries (2013-2018)
Figure North America Anti-inflammatory Therapeutics Sales Market Share by Countries in 2013
Figure North America Anti-inflammatory Therapeutics Sales Market Share by Countries in 2017
Table North America Anti-inflammatory Therapeutics Revenue by Countries (2013-2018)
Table North America Anti-inflammatory Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Anti-inflammatory Therapeutics Revenue Market Share by Countries in 2013
Figure North America Anti-inflammatory Therapeutics Revenue Market Share by Countries in 2017
Figure United States Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
Figure Canada Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
Figure Mexico Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
Figure Europe Anti-inflammatory Therapeutics Revenue and Growth Rate (2013-2018)
Table Europe Anti-inflammatory Therapeutics Sales by Countries (2013-2018)
Table Europe Anti-inflammatory Therapeutics Sales Market Share by Countries (2013-2018)
Table Europe Anti-inflammatory Therapeutics Revenue by Countries (2013-2018)
Figure Europe Anti-inflammatory Therapeutics Revenue Market Share by Countries in 2016
Figure Europe Anti-inflammatory Therapeutics Revenue Market Share by Countries in 2017
Figure Germany Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
Figure UK Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
Figure France Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
Figure Russia Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
Figure Italy Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Anti-inflammatory Therapeutics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Anti-inflammatory Therapeutics Sales by Countries (2013-2018)
Table Asia-Pacific Anti-inflammatory Therapeutics Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Anti-inflammatory Therapeutics Sales Market Share by Countries 2017
Table Asia-Pacific Anti-inflammatory Therapeutics Revenue by Countries (2013-2018)
Figure Asia-Pacific Anti-inflammatory Therapeutics Revenue Market Share by Countries 2017
Figure China Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
Figure Japan Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
Figure Korea Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
Figure India Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
Figure Southeast Asia Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
Figure South America Anti-inflammatory Therapeutics Revenue and Growth Rate (2013-2018)
Table South America Anti-inflammatory Therapeutics Sales by Countries (2013-2018)
Table South America Anti-inflammatory Therapeutics Sales Market Share by Countries (2013-2018)
Figure South America Anti-inflammatory Therapeutics Sales Market Share by Countries in 2017
Table South America Anti-inflammatory Therapeutics Revenue by Countries (2013-2018)
Table South America Anti-inflammatory Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Anti-inflammatory Therapeutics Revenue Market Share by Countries in 2017
Figure Brazil Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
Figure Argentina Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
Figure Colombia Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Anti-inflammatory Therapeutics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Anti-inflammatory Therapeutics Sales by Countries (2013-2018)
Table Middle East and Africa Anti-inflammatory Therapeutics Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Anti-inflammatory Therapeutics Sales Market Share by Countries in 2017
Table Middle East and Africa Anti-inflammatory Therapeutics Revenue by Countries (2013-2018)
Table Middle East and Africa Anti-inflammatory Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Anti-inflammatory Therapeutics Revenue Market Share by Countries in 2013
Figure Middle East and Africa Anti-inflammatory Therapeutics Revenue Market Share by Countries in 2017
Figure Saudi Arabia Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
Figure UAE Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
Figure Egypt Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
Figure Nigeria Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
Figure South Africa Anti-inflammatory Therapeutics Sales and Growth Rate (2013-2018)
Table Global Anti-inflammatory Therapeutics Sales by Type (2013-2018)
Table Global Anti-inflammatory Therapeutics Sales Share by Type (2013-2018)
Table Global Anti-inflammatory Therapeutics Revenue by Type (2013-2018)
Table Global Anti-inflammatory Therapeutics Revenue Share by Type (2013-2018)
Figure Global Anti-Inflammatory Biologicals Sales Growth (2013-2018)
Figure Global Anti-Inflammatory Biologicals Price (2013-2018)
Figure Global NSAIDs Sales Growth (2013-2018)
Figure Global NSAIDs Price (2013-2018)
Figure Global Corticosteroids Sales Growth (2013-2018)
Figure Global Corticosteroids Price (2013-2018)
Table Global Anti-inflammatory Therapeutics Sales by Application (2013-2018)
Table Global Anti-inflammatory Therapeutics Sales Share by Application (2013-2018)
Figure Global Clinics Sales Growth (2013-2018)
Figure Global Anti-inflammatory Therapeutics Sales, Revenue and Growth Rate (2018-2023)
Table Global Anti-inflammatory Therapeutics Sales Forecast by Regions (2018-2023)
Table Global Anti-inflammatory Therapeutics Market Share Forecast by Regions (2018-2023)
Figure North America Sales Anti-inflammatory Therapeutics Market Forecast (2018-2023)
Figure Europe Sales Anti-inflammatory Therapeutics Market Forecast (2018-2023)
Figure Asia-Pacific Sales Anti-inflammatory Therapeutics Market Forecast (2018-2023)
Figure South America Sales Anti-inflammatory Therapeutics Market Forecast (2018-2023)
Figure Middle East and Africa Sales Anti-inflammatory Therapeutics Market Forecast (2018-2023)
Table Global Anti-inflammatory Therapeutics Sales Forecast by Type (2018-2023)
Table Global Anti-inflammatory Therapeutics Market Share Forecast by Type (2018-2023)
Table Global Anti-inflammatory Therapeutics Sales Forecast by Application (2018-2023)
Table Global Anti-inflammatory Therapeutics Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...